Is serum amyloid A an endogenous TLR4 agonist?

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Serum amyloid A (SAA) is an acute-phase protein involved in inflammation.
• SAA primes leukocytes and promotes pro-inflammatory cytokine release.

Purpose of the Study:

• To investigate the role of SAA in nitric oxide (NO) production by macrophages.
• To elucidate the molecular mechanisms and receptor pathways involved in SAA-induced NO production.

Main Methods:

• Murine peritoneal macrophages were stimulated with SAA.
• Specific inhibitors and genetic knockout models (TLR4-deficient mice) were used.
• Analysis of NO production, inducible NO synthase (iNOS) activity, and MAPK signaling pathways (ERK1/2, p38).

Main Results:

• SAA significantly induced NO production in macrophages.
• NO production was dependent on inducible NO synthase (iNOS) activation via ERK1/2 and p38 MAPKs.
• SAA's activity was sensitive to proteolysis but not polymyxin B, suggesting a protein nature.
• NO production required functional Toll-like receptor 4 (TLR4); macrophages from TLR4-deficient mice did not respond to SAA.

Conclusions:

• SAA acts as an endogenous agonist for the TLR4 complex on macrophages.
• This interaction amplifies innate immunity during inflammatory processes.
• SAA-induced NO production is a novel mechanism contributing to the inflammatory response.